According to data from amfAR, the Foundation for AIDS Research, about 1.3 million people are on HIV/AIDS treatment in Kenya, ...
The U.S. government's foreign aid freeze has upended the supply chain for medical products crucial for fighting diseases ...
The freeze on U.S. foreign aid ordered by President Donald Trump has effectively halted one of the world's most successful ...
The Trump administration's global aid freeze is threatening the lives of HIV-positive orphans at Nyumbani Children's Home in ...
If PEPFAR is not reauthorized for the next four years, and without other resources for the HIV response, there would be 6.3 ...
Lenacapavir, a twice yearly injection that prevents HIV transmission, was named the breakthrough medicine of 2024. But ...
Persistence of stigma toward people living with HIV has puzzled scientists looking at the numerous destigmatization campaigns ...
Researchers at The Wistar Institute's HIV Cure and Viral Diseases Center have successfully identified a new approach using ...
A new HIV drug, lenacapavir, appears highly effective against strains circulating in Uganda, according to a study led by ...
A multi-national, multi-institutional study investigators found little natural resistance to a new HIV therapy called lenacapavir in a population of patients in Uganda.
The U.S. decision in January to freeze all funding for U.S. foreign assistance, including for the U.S. President's Emergency ...
Hosted on MSN5h
How the Health Department plans on easing the pressure caused by Trump's HIV fund cutsThe Department of Health said it would provide HIV patients with antiretrovirals for six months after the United States ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback